185 related articles for article (PubMed ID: 36921922)
1. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology.
Muraleetharan A; Wang Y; Rowe MC; Gould A; Gregory KJ; Hellyer SD
Mol Pharmacol; 2023 Jun; 103(6):325-338. PubMed ID: 36921922
[TBL] [Abstract][Full Text] [Related]
2. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
[TBL] [Abstract][Full Text] [Related]
4. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
5. Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
Arsova A; Møller TC; Vedel L; Hansen JL; Foster SR; Gregory KJ; Bräuner-Osborne H
Mol Pharmacol; 2020 Jul; 98(1):49-60. PubMed ID: 32358164
[TBL] [Abstract][Full Text] [Related]
6. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
[TBL] [Abstract][Full Text] [Related]
7. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism.
Sengmany K; Hellyer SD; Christopoulos A; Lapinsky DJ; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114011. PubMed ID: 32380090
[TBL] [Abstract][Full Text] [Related]
9. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
[TBL] [Abstract][Full Text] [Related]
10. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor 5 (mGlu
Hellyer SD; Albold S; Sengmany K; Singh J; Leach K; Gregory KJ
J Neurochem; 2019 Nov; 151(3):301-315. PubMed ID: 31376155
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.
Trinh PNH; May LT; Leach K; Gregory KJ
Clin Sci (Lond); 2018 Nov; 132(21):2323-2338. PubMed ID: 30389826
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia.
Bradley SJ; Langmead CJ; Watson JM; Challiss RA
Mol Pharmacol; 2011 May; 79(5):874-85. PubMed ID: 21321061
[TBL] [Abstract][Full Text] [Related]
15. Differential Pharmacology and Binding of mGlu
O'Brien DE; Shaw DM; Cho HP; Cross AJ; Wesolowski SS; Felts AS; Bergare J; Elmore CS; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2018 May; 93(5):526-540. PubMed ID: 29545267
[TBL] [Abstract][Full Text] [Related]
16. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ
J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377
[TBL] [Abstract][Full Text] [Related]
17. mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?
Dravolina OA; Zvartau E; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2017 May; 234(9-10):1333-1345. PubMed ID: 28285325
[TBL] [Abstract][Full Text] [Related]
18. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5.
Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151
[TBL] [Abstract][Full Text] [Related]
19. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
[TBL] [Abstract][Full Text] [Related]
20. Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.
Cho HP; Garcia-Barrantes PM; Brogan JT; Hopkins CR; Niswender CM; Rodriguez AL; Venable DF; Morrison RD; Bubser M; Daniels JS; Jones CK; Conn PJ; Lindsley CW
ACS Chem Biol; 2014 Oct; 9(10):2334-46. PubMed ID: 25137254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
